Sinopharm Tech Holdings (SEHK:8156) Income Statement Analysis 2001-2025

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Metric	2023	2024	LTM
Total Revenue	HK$41.277M	HK$61.253M	HK$69.124M
Cost of Sales	HK$36.258M	HK$47.738M	HK$56.415M
Gross Profit	HK$5.019M	HK$13.515M	HK$12.709M
Research And Development Expenses	-	-	-
Selling, General And Administrative Expenses	HK$14.182M	HK$20.643M	HK$19.404M
Other Expenses	HK$1.239M	-	-
Operating Profit	HK$-9.163M	HK$-7.128M	HK$-6.695M
Net Interest Income	HK$-23.849M	HK$-5.851M	HK$-4.61M
Other Non-operating Income	HK$12.68M	HK$11.9M	HK$11.005M
Total Non-operating Income	HK$-11.169M	HK$6.049M	HK$6.395M
EBT	HK$-20.332M	HK$-1.079M	HK$-0.3M
Income Tax Expense	HK$83K	HK$291K	HK$420K
Net Income	HK$-19.698M	HK$-0.867M	HK$0.965M

Earnings Per Share (Basic)	HK$-0.11	HK$-0.002	HK$0.003
Earnings Per Share (Diluted)	HK$-0.11	HK$-0.002	HK$0.003
Weighted-Average Shares Outstanding (Basic)	HK$0.184B	HK$0.465B	HK$1.267B
Weighted-Average Shares Outstanding (Diluted)	HK$0.184B	HK$0.465B	HK$1.267B

EBITDA	HK$4.979M	HK$6.108M	HK$5.614M
Depreciation And Amortization	HK$1.378M	HK$1.333M	HK$1.311M
EBIT	HK$3.601M	HK$4.775M	HK$4.303M

Sinopharm Tech Holdings Income Statement

Revenue And Expenses Breakdown